#treatment access

Abu-Jamal spent years fighting for access to hepatitis C treatment in prison.

This is one of several lawsuits filed by advocates on behalf of inmates with the liver virus in U.S. prisons.

The state would pay a fixed annual amount for an unlimited supply of HCV drugs for its Medicaid program.

In a recent settlement, the state agreed to expand coverage of HCV treatment—but only to those with advanced liver scarring.

The state is appealing a ruling that requires the prison system to properly treat inmates with the virus.

The Trump administration had proposed changing which meds were covered, including HIV and cancer drugs.

A recent article in The Seattle Times asks why.

Are subscription treatment models the future of hepatitis C treatment?

The subscription-based model is the first of its kind.

The right was secured via a class-action lawsuit settlement.

Stop me if you’ve heard this one before.

Advocates say out of some 3,000 inmates recently diagnosed with the virus, just 46 have received any sort of treatment.

The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.

Three lawsuits allege prison officials denied them treatment for more than a year, despite serious illness.

Lawsuits across the country are demanding access to treatment for incarcerated populations. Here’s why.

Louisiana health officials are adopting the country’s first subscription model for hep C cures.